geninus Venture Capital

3 known investors

Geninus develops IntelliMed, a platform that uses multimodal spatial transcriptomics and patient data to discover novel drug targets for oncology, particularly for modalities like TCEs and ADCs. The platform combines spatial genomics, protein profiling, and clinical outcomes to enable target discovery with reduced biological risk.

AI & Machine LearningBiotechDeep Tech